INMED PHARMACEUTICALS INC. Costs and Expenses
INMED PHARMACEUTICALS INC. (INM) reported Costs and Expenses of -$2.34 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2023-05-15
- INMED PHARMACEUTICALS INC. costs and expenses for the quarter ending 2023-03-31 was -$2.34M.
- INMED PHARMACEUTICALS INC. costs and expenses for the quarter ending 2022-12-31 was -$2.37M.
- INMED PHARMACEUTICALS INC. costs and expenses for the quarter ending 2022-09-30 was $3.83M, a 28.92% increase year-over-year.
- INMED PHARMACEUTICALS INC. costs and expenses for the quarter ending 2022-03-31 was -$3.72M.
| Period end | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month |
|---|---|---|---|
| 2023-03-31 | -$2.34M 10-Q · filed 2023-05-15 | -$4.71M derived: sum of 2 quarters · filed 2023-05-15 | -$7.70M 10-Q · filed 2023-05-15 |
| 2022-12-31 | -$2.37M 10-Q · filed 2023-02-17 | -$5.35M 10-Q · filed 2023-02-17 | |
| 2022-09-30 | $3.83M 10-Q · filed 2022-11-14 | ||
| 2022-03-31 | -$3.72M 10-Q · filed 2023-05-15 | -$8.15M derived: sum of 2 quarters · filed 2023-05-15 | -$11.04M 10-Q · filed 2023-05-15 |
| 2021-12-31 | -$4.42M 10-Q · filed 2023-02-17 | -$7.32M 10-Q · filed 2023-02-17 | |
| 2021-09-30 | $2.97M 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |